MariMed Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- NOTE 1 - DESCRIPTION OF BUSINESS & SUMMARY OF ACCTING POLICIES (Policies)
Notes Tables
Notes Details

NOTE 3 - USE OF EQUITY AS COMPENSATION

NOTE 3 - USE OF EQUITY AS COMPENSATION	3 Months Ended
Mar. 31, 2016
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
NOTE 3 – USE OF EQUITY AS COMPENSATION	NOTE 3 - USE OF EQUITY AS COMPENSATION In the past the Company has issued shares of common stock as payment for services rendered. No shares were issued during the three months ended March 31, 2016 or 2015.

NOTE 3 - USE OF EQUITY AS COMPENSATION

3 Months Ended

Mar. 31, 2016

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

NOTE 3 – USE OF EQUITY AS COMPENSATION

NOTE 3 - USE OF EQUITY AS COMPENSATION

In the past the Company has issued shares of common stock as payment for services rendered. No shares were issued during the three months ended March 31, 2016 or 2015.